1-7 of 7
Eric D. Hsi
Close
Sort by
Journal Articles

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Clinical Trials & Observations
Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina Wagner-Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3189–3199.
https://doi.org/10.1182/bloodadvances.2023011657
Published: 2024
Includes: Supplemental data
Journal Articles

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

David A. Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F. Cashen, Neha Mehta-Shah, Brad S. Kahl, Nancy L. Bartlett, Juan P. Alderuccio, Izidore S. Lossos, Sarah L. Ondrejka, Eric D. Hsi, Peter Martin, John P. Leonard, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5524–5539.
https://doi.org/10.1182/bloodadvances.2023010779
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Yong Li, Zijun Y. Xu-Monette, Jeremy Abramson, Aliyah R. Sohani, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Shanxiang Zhang, Karen Dybkaer, Zenggang Pan, Min Xu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Heounjeong Go, J. Han van Krieken, Jane N. Winter, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Miguel A. Piris, Yingjun Wang, Mingzhi Zhang, Ken H. Young
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1308–1311.
https://doi.org/10.1182/bloodadvances.2022008550
Published: 2023
Includes: Supplemental data
Journal Articles

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Zijun Y. Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Carlo Visco, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick B. Hagemeister, Babak Shahbaba, Ivan De Dios, Hong Zhang, Yong Li, Bing Xu, Maher Albitar, Ken H. Young
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3391–3404.
https://doi.org/10.1182/bloodadvances.2020001949
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy

Clinical Trials & Observations
Daniel J. Landsburg, Mitchell E. Hughes, Alexa Koike, David Bond, Kami J. Maddocks, Ling Guo, Allison M. Winter, Brian T. Hill, Sarah L. Ondrejka, Eric D. Hsi, Sunita D. Nasta, Jakub Svoboda, Stephen J. Schuster, Agata M. Bogusz
Journal: Blood Advances
Blood Adv (2019) 3 (2): 132–135.
https://doi.org/10.1182/bloodadvances.2018026401
Published: 2019
Journal Articles

CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

Ying-Ping Jiang, Bob Y. Liu, Quan Zheng, Swapna Panuganti, Ruoying Chen, Jianyu Zhu, Madhavi Mishra, Jianqing Huang, Trang Dao-Pick, Sharmili Roy, XiaoXian Zhao, Jeffrey Lin, Gautam Banik, Eric D. Hsi, Ramkumar Mandalam, Jagath R. Junutula
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1738–1749.
https://doi.org/10.1182/bloodadvances.2018020107
Published: 2018
Includes: Supplemental data